NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Belinson S, Yang Y, Chopra R, et al. Local Therapies for Unresectable Primary Hepatocellular Carcinoma [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 May. (Comparative Effectiveness Reviews, No. 114.)
This publication is provided for historical reference only and the information may be out of date.
| Acronym | Definition |
|---|---|
| 3D-CRT | Three dimensional conformal radiotherapy |
| AES | Adverse events |
| AHRQ | Agency for Healthcare Research and Quality |
| AJCC | American Joint Committee on Cancer |
| ALT | Alanine aminotransferase |
| AST | Aspartate transaminase |
| BCLC | Barcelona Clinic Liver Cancer |
| CAT | Computed axial tomography |
| CER | Comparative effectiveness review |
| CLIP | Cancer of the Liver Italian Program |
| CRT | Conformal Radiation Therapy |
| CT | Computed tomography |
| CP | Child-tucotte-Pugh |
| CUPI | Chinese University Prognostic Index |
| DEB | Drug-eluting Beads |
| ECOG | Eastern Cooperative Oncology Group |
| EPC | Evidence-based Practice Center |
| GETCH | Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire |
| GRADE | Grading of Recommendations Assessment, Development and Evaluation |
| HAI | Hepatic arterial infusion |
| HBV | Hepatitis B Virus |
| HCC | Hepatocellular carcinoma |
| HCV | Hepatitis C Virus |
| HDR | High-dose rate |
| IMRT | Intensity Modulated Radiation Therapy |
| INR | International normalized ratio |
| IQR | Inter-quartile range |
| JIS | Japan Integrated Staging |
| LDR | Low-dose rate |
| LDT | Liver directed therapy |
| LOS | Length of stay |
| MAA | 99mTc-macro-aggregated albumin |
| MELD | Model for End-Stage Liver Disease |
| MRI | Magnetic resonance imaging |
| MWA | Microwave ablation |
| NAFLD | Non-alcoholic fatty liver disease |
| NCCN | National Comprehensive Cancer Network |
| NIH | National Institutes of Health |
| PAI | Percutaneous alcohol injection |
| PDR | Pulsed-dose rate |
| PEA | Percutaneous ethanol ablation |
| PEI | Percutaneous ethanol infusion |
| PFS | Progression-free survival |
| PICOTS | population, intervention, comparator, outcomes, timing, and setting |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analysis |
| PVT | Portal vein thrombosis |
| QOL | Quality of life |
| RCT | Randomized controlled trial |
| RFA | Radiofrequency ablation |
| RFTA | Radiofrequency thermal ablation |
| RTRT | Real-time target tracking |
| SBRT | Stereotactic body radiation therapy |
| SCHIP | State Children's Health Insurance Program |
| SOE | Strength of evidence |
| SRC | Scientific Resource Center |
| TACE | Transarterial chemoembolization |
| TAE | Transarterial embolization |
| TEA | Transarterial ethanol ablation |
| TEP | Technical expert panel |
| TMN | Tumor, Node, Metastases |
| TTP | Time to progression |
| US | Ultrasound |
| Y90 | Yittrium-90 |
- Abbreviations and Acronyms - Local Therapies for Unresectable Primary Hepatocell...Abbreviations and Acronyms - Local Therapies for Unresectable Primary Hepatocellular Carcinoma
- Data Abstraction Tables - Screening for Methicillin-Resistant Staphylococcus Aur...Data Abstraction Tables - Screening for Methicillin-Resistant Staphylococcus Aureus (MRSA)
- Outcomes for Specific Subgroups of Interest: Detailed Study Findings - Stroke Pr...Outcomes for Specific Subgroups of Interest: Detailed Study Findings - Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update
- Technical Expert Panel - Nonsurgical Treatments for Urinary Incontinence in Adul...Technical Expert Panel - Nonsurgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness
- cysteinyl leukotriene receptor 1 isoform a [Mus musculus]cysteinyl leukotriene receptor 1 isoform a [Mus musculus]gi|31542449|ref|NP_067451.2|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...